Nanjing, China

Jun Ge

This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Grand Theravac Life Sciences (Nanjing) Co., Ltd., Grand Theravac Life Science (Nanjing) Co., Ltd., Jiangsu Theravac Bio-Pharmaceutical Co., Ltd.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Ge. Retrieved from https://idiyas.com/inventor/jun-ge-sa1tb4nk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 10.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Jun Ge

Introduction

Jun Ge is an accomplished inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for hepatitis B. With a total of two patents to his name, his work has the potential to impact the healthcare industry significantly.

Latest Patents

Jun Ge's latest patents include a pharmaceutical preparation for treating hepatitis B and a novel hepatitis B vaccine. The first patent discloses a pharmaceutical preparation containing hepatitis B surface antigen, hepatitis B core antigen, and an oligodeoxynucleotide solution. This preparation is designed to be free of saccharides, showcasing a simple composition with excellent antigen stability and minimal adverse reactions caused by traditional aluminum adjuvants. Long-term stability experiments have shown promising preservation effects.

His second patent presents a hepatitis B vaccine composition that includes important components such as HBsAg and HBcAg1-X, as well as a phosphorothioate oligonucleotide known as CpG-ODN. This innovative composition targets the treatment of HBV infection and associated diseases, outlining effective therapy methodologies for these conditions.

Career Highlights

Throughout his career, Jun Ge has been affiliated with reputable organizations, notably Jiangsu Theravac Bio-pharmaceutical Co., Ltd. and Grand Theravac Life Sciences (Nanjing) Co., Ltd. His work at these companies has likely facilitated his innovative research and developments in hepatitis B treatments.

Collaborations

Jun Ge has collaborated with esteemed colleagues such as Tong Zhou and Jianqiang Li. Their combined efforts have undoubtedly contributed to the advancement of research in the biopharmaceutical field.

Conclusion

With his innovative approaches and significant patents, Jun Ge stands out as a remarkable figure in the scientific community. His contributions to hepatitis B treatment exemplify the impact that dedicated inventors can have on public health and medical advancements. As he continues his work, it will be exciting to see what future innovations he brings to the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…